These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26546479)

  • 21. Decreased adiponectin links elevated adipose tissue autophagy with adipocyte endocrine dysfunction in obesity.
    Slutsky N; Vatarescu M; Haim Y; Goldstein N; Kirshtein B; Harman-Boehm I; Gepner Y; Shai I; Bashan N; Blüher M; Rudich A
    Int J Obes (Lond); 2016 Jun; 40(6):912-20. PubMed ID: 26786352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of cerebrovascular disease when there is concomitant Alzheimer disease.
    Vemuri P; Knopman DS
    Biochim Biophys Acta; 2016 May; 1862(5):952-6. PubMed ID: 26408957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity, leptin, and Alzheimer's disease.
    Lee EB
    Ann N Y Acad Sci; 2011 Dec; 1243():15-29. PubMed ID: 22211890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leptin in Alzheimer's disease.
    Magalhães CA; Carvalho MG; Sousa LP; Caramelli P; Gomes KB
    Clin Chim Acta; 2015 Oct; 450():162-8. PubMed ID: 26279362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk factors and glucose tolerance in midlife and risk of cognitive disorders in old age up to a 49-year follow-up of the Helsinki businessmen study.
    Rantanen K; Strandberg AY; Salomaa V; Pitkälä K; Tilvis RS; Tienari P; Strandberg T
    Ann Med; 2017 Sep; 49(6):462-469. PubMed ID: 28151011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice.
    Robert J; Stukas S; Button E; Cheng WH; Lee M; Fan J; Wilkinson A; Kulic I; Wright SD; Wellington CL
    Biochim Biophys Acta; 2016 May; 1862(5):1027-36. PubMed ID: 26454209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia.
    Akinyemi RO; Mukaetova-Ladinska EB; Attems J; Ihara M; Kalaria RN
    Curr Alzheimer Res; 2013 Jul; 10(6):642-53. PubMed ID: 23627757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular cognitive impairment.
    Selnes OA; Vinters HV
    Nat Clin Pract Neurol; 2006 Oct; 2(10):538-47. PubMed ID: 16990827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease.
    Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO
    Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic actions of adipocyte hormones: focus on adiponectin.
    Ahima RS
    Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():9S-15S. PubMed ID: 16642957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiponectin and sporadic Alzheimer's disease: Clinical and molecular links.
    Letra L; Rodrigues T; Matafome P; Santana I; Seiça R
    Front Neuroendocrinol; 2019 Jan; 52():1-11. PubMed ID: 29038028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism.
    Nixon DW
    Curr Alzheimer Res; 2017; 14(8):883-893. PubMed ID: 28215174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.
    Van Nostrand WE
    Biochim Biophys Acta; 2016 May; 1862(5):1018-26. PubMed ID: 26519139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer disease and cerebrovascular pathology: an update.
    Jellinger KA
    J Neural Transm (Vienna); 2002 May; 109(5-6):813-36. PubMed ID: 12111471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance in the brain: an old-age or new-age problem?
    Williamson R; McNeilly A; Sutherland C
    Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.
    Kivipelto M; Ngandu T; Fratiglioni L; Viitanen M; Kåreholt I; Winblad B; Helkala EL; Tuomilehto J; Soininen H; Nissinen A
    Arch Neurol; 2005 Oct; 62(10):1556-60. PubMed ID: 16216938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vascular risk factors in demented elderly: analysis of Alzheimer Clinic materials].
    Czyzewski K; Pfeffer A; Wasiak B; Łuczywek E; Gołebiowski M; Styczyńska M; Barcikowska M
    Neurol Neurochir Pol; 2001; 35(3):405-13. PubMed ID: 11732264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease. Part I: Pathology, diagnosis and screening.
    Davey DA
    Neurodegener Dis Manag; 2014; 4(3):253-9. PubMed ID: 25095819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-evaluating the role of vascular changes in the differential diagnosis of Alzheimer's disease and vascular dementia.
    Gold G; Giannakopoulos P; Bouras C
    Eur Neurol; 1998 Oct; 40(3):121-9. PubMed ID: 9748669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.